Nutritional supplements like Lingonberry have many health benefits and are being widely used by cancer patients and those at-genetic-risk of cancer. But, is it safe to take Lingonberry supplements for all types of cancer and without considering any ongoing treatments and other lifestyle conditions? A common belief but only a myth is that anything natural can only benefit me or do no harm. As one example, the use of grapefruit with certain medications is not recommended. Another example, the use of spinach with some blood thinning medications can cause adverse interactions and should be avoided. For cancer, nutrition which includes the food and natural supplements has been shown to influence outcomes. Hence a frequently asked question by cancer patients to dieticians and doctors is “What Should I eat and What Should I Avoid?”.
Taking nutritional Lingonberry supplements can benefit cancer patients with Juvenile Myelomonocytic Leukemia on Trametinib treatment. But avoid Lingonberry supplements if on Carmustine treatment for Pineoblastoma. Similarly, taking nutritional supplement Lingonberry can benefit healthy individuals who are at genetic risk of cancer due to mutation of gene PDGFRA. But avoid taking nutritional supplement Lingonberry when at genetic risk of cancer due to mutation of gene ERCC2.
The takeaway being – your individual context will influence your decision if nutritional supplement Lingonberry is safe or not. And also that this decision needs to be constantly revisited as conditions change. Conditions like cancer type, current ongoing treatments and supplements, age, gender, weight, height, lifestyle and any genetic mutations identified matter. So a legitimate question for you to ask for any recommendation of food and natural supplement is how it is related to your individual context.
Nutritional supplements – vitamins, herbs, minerals, probiotics, and other specialty categories are increasing. Supplements are high concentrations of active ingredients which are also found in different foods. The difference being foods contain more than one active ingredient at lower diffused concentrations. Remember that each of these ingredients has its own science and biological mechanism at molecular level – hence choose the right combination of supplements like Lingonberry based on individual context and conditions.
So the question is should you take supplement Lingonberry? Should you take it when at genetic risk of cancer for mutation of gene ERCC2? Should you take it when at genetic risk of cancer for mutation of gene PDGFRA? Should you take it when diagnosed with Pineoblastoma? Should you take Lingonberry supplement when diagnosed with Juvenile Myelomonocytic Leukemia? Should you take it when on Carmustine treatment? Should you continue taking it if you change your treatment from Carmustine to Trametinib? So a general explanation like – it is natural or it increases immunity may not be acceptable and sufficient for choosing Lingonberry.
Cancer remains an unsolved problem statement. The improved availability of personalized treatments and monitoring of cancer via blood and saliva have been significant factors to improve outcomes. The earlier the intervention – the better the influence on outcome. Genetic testing has the potential to assess cancer risk and susceptibility early. But besides regular monitoring in most cases there are no therapeutic intervention options available. After diagnosis with cancer such as Pineoblastoma or Juvenile Myelomonocytic Leukemia, the treatments get personalized to tumor genomics and factors like staging of disease, age and gender. During cancer remission (after treatment cycle is complete) – monitoring is used for assessment of any relapse and accordingly decide next steps. A large majority of cancer patients and those at-risk do take nutritional supplements like Lingonberry.
So the question is that are all genetic mutation risks and types of cancers to be considered as one when deciding the use of Lingonberry? Are the biochemical pathway implications of genetic risk for cancer due to mutation of gene ERCC2 the same as due to mutation of gene PDGFRA? Are the implications of Pineoblastoma same as Juvenile Myelomonocytic Leukemia? Is it one and the same if you are on treatment with Carmustine or on Trametinib?
Lingonberry – A Nutritional Supplement
Lingonberries are sour to bitter in taste and are mainly grown in Europe. They are rich in anthocyanin glycosides. Both, the leaves and berries have medicinal properties. The benefits of consuming lingonberry are :
- Has antioxidant and anti-inflammatory effect
- Helps in cure of urinary tract infections
- Helps in weight management
- Helps in kidney stone
- Protective effect on eyes
- Possesses anticancer effect (Marjo Misikangas et al, The Journal of Nutrition, 2007; Zi-Luan Fan et al,Food Chemistry, 2011)
Lingonberry supplements contain many active ingredients including Arbutin, Fraxin, Resveratrol and Quercetin at different concentration levels. The molecular pathways which are regulated by Lingonberry include Cancer Epigenetics, RAS-RAF Signaling, Stem Cell Signaling, PI3K-AKT-MTOR Signaling and MAPK Signaling. These cellular pathways directly or indirectly regulate specific cancer molecular endpoints like growth, spread and death. Because of this biological regulation – for cancer nutrition, the right choice of supplements like Lingonberry individually or in combination is an important decision to be made. When making decisions on the use of supplement Lingonberry for cancer – do consider all these factors and explanations. Because just as true for cancer treatments – Lingonberry use cannot be a one-size-fits-all decision for all types of cancers.
Choosing Lingonberry Supplements for Your Cancer
The reason there is no easy way to answer the question “When should I avoid Lingonberry for Cancer” is because “It Depends!”. Just like the same treatment does not work for every cancer patient, based on your individual context the Lingonberry may be harmful or safe. Along with which cancer and associated genetics – the ongoing treatments, supplements, lifestyle habits, BMI and allergies are all factors deciding if Lingonberry should be avoided or not and why.
1. Will Lingonberry Supplements benefit Cancer Patients with Pineoblastoma undergoing Carmustine treatment?
Pineoblastoma is characterized and driven by specific genetic mutations like ATR and ATM leading to biochemical pathway changes in Cancer Epigenetics, PI3K-AKT-MTOR Signaling, DNA Repair and EPHRIN Signaling. A cancer treatment like Carmustine works through a specific pathway mechanism of action. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach which is effective. In such a condition any food or nutritional supplement which has a contrary effect to the treatment or reduces the overlap should be avoided. As an example, Lingonberry supplement should be avoided for Pineoblastoma along with treatment Carmustine. Lingonberry supplement impacts pathways/processes like Cancer Epigenetics and DNA Repair Signaling which either promote drivers of the Pineoblastoma and/or nullify the treatment effect. Some of the factors which should be considered when choosing nutrition are type of cancer, treatments and supplements being taken currently (if any), age, gender, BMI, lifestyle and any genetic mutation information (if available).
2. Will Lingonberry Supplements benefit Cancer Patients with Juvenile Myelomonocytic Leukemia undergoing Trametinib Treatment?
Juvenile Myelomonocytic Leukemia is characterized and driven by specific genetic mutations like PTPN11 and NRAS leading to biochemical pathway changes in RAS-RAF Signaling, MAPK Signaling, PI3K-AKT-MTOR Signaling and MYC Signaling. A cancer treatment like Trametinib works through specific pathway mechanisms. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach. In such a condition any food or nutritional supplement which has a compatible effect to the treatment or reduces the overlap should be considered. As an example, Lingonberry supplement should be considered for Juvenile Myelomonocytic Leukemia along with treatment Trametinib. Lingonberry supplement impacts pathways/processes like RAS-RAF Signaling, MAPK Signaling and MYC Signaling which either obstruct drivers of the Juvenile Myelomonocytic Leukemia and/or improve the treatment effect.
Foods to Eat After Cancer Diagnosis!
No two cancers are the same. Go beyond the common nutrition guidelines for everyone and make personalized decisions about food and supplements with confidence.
3. Are Lingonberry Supplements Safe for Healthy Individuals with ERCC2 Mutation Associated Genetic Risk?
Different companies offer panels of genes to be tested for assessing genetic risk to different cancers. These panels cover genes associated with cancers of the breast, ovary, uterus, prostate, and gastrointestinal system and others. Genetic testing of these genes may confirm a diagnosis and help guide treatment and management decisions. Identification of a disease-causing variant may also guide testing and diagnosis of at-risk relatives. ERCC2 is one of the genes generally available in panels for cancer risk testing.
ERCC2 mutation causes biochemical pathways Stem Cell Signaling, MAPK Signaling, DNA Repair, Angiogenesis and Cancer Epigenetics to get impacted. These pathways are direct or indirect drivers of cancer molecular endpoints. Lingonberry should be avoided when the genetic panel identifies mutation of ERCC2 for Skin Cancer. Lingonberry supplement impacts pathways/processes like DNA Repair and Cancer Epigenetics and creates adverse effects with ERCC2 and related conditions.
4. Are Lingonberry Supplements Safe for Healthy Individuals with PDGFRA Mutation Associated Genetic Risk?
PDGFRA is one of the genes available in panels for cancer risk testing. PDGFRA mutation causes biochemical pathways Stem Cell Signaling, Angiogenesis, RAS-RAF Signaling, PI3K-AKT-MTOR Signaling and Growth Factor Signaling to get impacted. These pathways are direct or indirect drivers of cancer molecular endpoints. Consider taking Lingonberry supplement when the genetic panel identifies mutations in PDGFRA for Gastric Cancer. Lingonberry supplement impacts pathways/processes like Stem Cell Signaling, Angiogenesis and RAS-RAF Signaling and creates a protective effect in those with PDGFRA mutations and related conditions.
* Other Factors are also included like BMI, Lifestyle Habits, Treatments
The two most important things to remember are that cancer treatments and nutrition are never the same for everyone. Nutrition which includes food and nutritional supplements like Lingonberry, is an effective tool which can be controlled by you, while facing cancer.
What food you eat and which supplements you take is a decision you make. Your decision should include consideration of the cancer gene mutations, which cancer, ongoing treatments and supplements, any allergies, lifestyle information, weight, height and habits.
The nutrition planning for cancer from addon is not based on internet searches. It automates the decision making for you based on molecular science implemented by our scientists and software engineers. Irrespective of whether you care to understand the underlying biochemical molecular pathways or not - for nutrition planning for cancer that understanding is needed.
Get started NOW with your nutrition planning by answering questions on the name of cancer, genetic mutations, ongoing treatments and supplements, any allergies, habits, lifestyle, age group and gender.
Personalized Nutrition for Cancer!
Cancer changes with time. Customize and modify your nutrition based on cancer indication, treatments, lifestyle, food preferences, allergies and other factors.
Cancer patients often have to deal with different chemotherapy side effects which affect their quality of life and look out for alternative therapies for cancer. Taking the right nutrition and supplements based on scientific considerations (avoiding guesswork and random selection) is the best natural remedy for cancer and treatment related side-effects.